Professor Colón's Advance Article on nanoparticles for drug delivery in cancer therapy is published on the Chemical Communications website
Together with his former graduate student Dr. Agustín Díaz (currently a Ford Foundation Diversity Postdoctoral Fellow at Texas A&M University), his graduate student Barbara Casañas, his former undergraduate student Amanda David (currently a graduate student at Texas A&M University), his undergraduate student Julissa González, and his collaborators at Texas A&M University Dr. Abraham Clearfield, Dr. James Batteas, and Dr. M. Delwar Hussain, and their students, Professor Jorge L. Colón work was published online on Chemical Communications, the leading weekly journal for the publication of communications on important developments in the chemical sciences.
In this study, they intercalated the anti-cancer drug doxorubicin in layered zirconium phosphate nanoplatelets and demonstrated the use of this material to deliver the drug to breast cancer cells (MCF-7), showing higher uptake and cytotoxicity of doxorubicin-loaded materials compared to free doxorubicin.
For details, see "Zirconium phosphate nano-platelets: a novel platform for drug delivery in cancer therapy”, Agustín Díaz, Vipin Saxena, Julissa González, Amanda David, Barbara Casañas, James D. Batteas, Jorge L. Colón, Abraham Clearfield, and M. Delwar Hussain, Chem. Commun. 2012, in press. Advance Article http://dx.doi.org/10.1039/C2CC16218K